Drug Utilization Review Alerts as Treatment Complexity Evidence in PI Cases

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | March 4, 2026 | 8 min read

Drug utilization review (DUR) alerts are system-generated clinical warnings triggered when a plaintiff's medication regimen meets criteria for potential safety concerns. The volume and type of DUR alerts in a case objectively document treatment complexity caused by accident-related injuries.

Drug utilization review (DUR) alerts are automated clinical warnings generated by pharmacy information systems when a patient's medication profile triggers safety criteria -- duplicate therapy, therapeutic duplication, drug-age precautions, dose range violations, drug-disease interactions, and more. In personal injury cases, the volume and nature of DUR alerts generated by a plaintiff's medication regimen provide objective, system-generated evidence of treatment complexity that is independent of any human narrative or subjective assessment.

• DUR alerts are algorithm-driven clinical warnings generated by pharmacy systems, not by human judgment or litigation strategy
• The number of DUR alerts triggered by a plaintiff's medication profile directly correlates with regimen complexity
• LienScripts reviews and resolves all DUR alerts for every case, and each case receives a MERIT (Medication Evaluation & Rationale for Injury Treatment) report documenting clinically significant alerts and their resolution
• DUR alert data is objective -- it is generated by the same systems used by every pharmacy in the country under federal and state regulatory requirements
• High DUR alert volume demonstrates that the plaintiff's medication management requires clinical expertise beyond routine dispensing

What Drug Utilization Review Is

Federal law (OBRA-90) and state pharmacy practice acts require pharmacies to conduct prospective drug utilization review on every prescription before dispensing. This review uses automated algorithms to screen for:

• Drug-drug interactions -- two or more medications that interact adversely
• Therapeutic duplication -- two medications from the same class prescribed concurrently
• Dose range alerts -- doses that exceed standard ranges
• Drug-age contraindications -- medications inappropriate for the patient's age
• Drug-disease interactions -- medications contraindicated with the patient's diagnosed conditions
• Duration of therapy -- treatment courses that exceed typical durations
• Early refill detection -- attempts to fill before the expected refill date

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "Every prescription I process goes through DUR screening. In a straightforward case -- one or two medications -- the system generates minimal alerts. But when I process prescriptions for a PI patient on six or seven concurrent medications, the alert volume increases substantially. Each alert requires my clinical assessment: Is this interaction clinically significant given the patient's specific situation? Does this duplication serve a therapeutic purpose? Is this dose appropriate for this injury severity? The alert count itself is an objective measure of how complex this patient's medication management has become."

DUR Alert Volume as Complexity Metric

The number of DUR alerts triggered by a plaintiff's medication profile is a quantifiable metric. A patient on two medications may generate zero or one alert. A patient on six concurrent injury-related medications may generate eight, ten, or more alerts. This is not speculation -- it is math. More medications create exponentially more potential interactions and duplications, and the pharmacy system quantifies this with each fill.

Presenting the DUR alert count as a treatment complexity metric in demand packages transforms an abstract claim of "complex treatment" into a specific, verifiable number.

Types of DUR Alerts in PI Cases

Concurrent CNS Depressant Alerts

The most common DUR alert in PI cases involves concurrent use of central nervous system depressants -- opioids, muscle relaxants, benzodiazepines, and gabapentinoids prescribed together for pain, muscle spasm, and anxiety. The pharmacy system flags each combination, and the pharmacist must assess whether the concurrent use is appropriate for the clinical situation.

Therapeutic Duplication Alerts

When a plaintiff is prescribed two NSAIDs (for example, meloxicam for daily use and ketorolac for acute flares), or two muscle relaxants (cyclobenzaprine during the day and tizanidine at night), the system generates a therapeutic duplication alert. While therapeutic duplication may be clinically intentional, each alert documents the pharmacist's clinical decision to proceed with a complex regimen.

Dose Range Alerts

When a plaintiff's medication is titrated to the maximum dose or beyond typical ranges, dose range alerts are triggered. These alerts document that the plaintiff's dosing requirements exceed standard parameters -- an objective indicator that the injury is severe enough to require aggressive dosing.

Duration of Therapy Alerts

Long-term use of medications typically prescribed for short courses (such as muscle relaxants or high-dose NSAIDs) triggers duration alerts. These alerts document that the plaintiff's condition has persisted beyond the expected treatment duration, supporting arguments about chronic injury.

How LienScripts Manages DUR Alerts

At LienScripts, every DUR alert is reviewed by a clinical pharmacist who assesses the alert in context of the plaintiff's complete medication profile and injury history. Alerts that represent genuine clinical concerns are escalated to the prescriber. Alerts that are clinically appropriate given the injury context are documented with the pharmacist's clinical rationale for proceeding.

This process generates a comprehensive record of clinical decision-making that is included in the MERIT report. The report details which alerts were generated, how they were resolved, and why the pharmacist determined the medication regimen was appropriate -- providing adjusters and juries with a pharmacist-authored explanation of treatment complexity.

Presenting DUR Evidence in Demand Packages

Include DUR alert analysis in demand packages to quantify treatment complexity:

1. Total alert count -- the number of DUR alerts generated over the treatment period
2. Alert categories -- grouping alerts by type (interaction, duplication, dose range, duration)
3. Clinical resolution -- how each alert was assessed and resolved by the pharmacist
4. Comparison to baseline -- noting that pre-accident medication profiles generated zero or minimal alerts
5. Ongoing monitoring -- documenting that continued DUR review is required at each refill

LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages that includes DUR alert analysis with clinical context.

Practical Takeaways

DUR alerts are objective, system-generated evidence of medication regimen complexity. They require no subjective interpretation to demonstrate that a plaintiff's treatment is clinically complex -- the pharmacy system quantifies it automatically. Attorneys who present DUR alert data from LienScripts transform the abstract concept of "treatment complexity" into a specific, verifiable metric that defense counsel cannot challenge as opinion or exaggeration.

Related Resources

• Pharmacist Drug Interaction Interventions -- How interaction interventions document treatment complexity
• Polypharmacy Burden as a Damages Element -- The damages impact of managing multiple medications
• What Is a MERIT Report? -- Understanding the pharmacist-authored clinical summary